Jane Henderson, Senior V.P. & CFO, Corporate Development at Voyager Therapeutics, Inc. (VYGR), sold 31,100 shares at $20.52 ($649K) on 2018-03-23, disclosed to the SEC on 2018-03-26.
Open-market sale of $649k VYGR by Senior V.P. & CFO, Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.07 | 19,900 | $419K | 64.6% |
| 2 | $20.52 | 11,200 | $230K | 35.4% |
| Total | $20.87 avg | 31,100 | $649K | 100% |
| Filing → |
| APGE | SELL | 2026-04-03 | $170K | — | Filing → |
| APGE | SELL | 2026-03-27 | $170K | — | Filing → |
| APGE | SELL | 2026-03-04 | $140K | — | Filing → |